Zinc Oxide VS MEBO
ConditionsPressure InjuryPressure Injury Stage 2BedsorePressure Ulcers Stage IIPressure Ulcer, Buttock
Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18+
SponsorKing Abdullah Medical City
About this trial
randomize control trial to evaluate the efficacy of using zinc oxide versus moist exposed wound ointment in treatment of second stage pressure ulcer.
Eligibility criteria
Qualifiers
Willing to participate.
KAMC cases in medical ward, neuroscience ward, and intensive care unit.
Newly cases diagnosed with second stage pressure ulcer according to the European pressure ulcer advisory panel/national pressure ulcer advisory panel (NPUAP) guidelines.
Disqualifiers
Not consenting to participate
Patients with suspected hypersensitivity reactions to any of the topical formulation's ingredients.
Either a category III or IV pressure ulcer.
Evidence of deep tissue injury (exudative drainage, purple or maroon localized area of discolored intact skin or blood-filled blister due to pressure damage).
Trial design
Treatments tested in this trial
- MEBO Wound Ointment
- zinc oxide
Treatment groups
76 Participants
are divided into 2 treatment groupsLocations
2King Abdulla Medical City in Holy capital24211, MeccaWestern Reagan, Saudi Arabia
King Abdulla Medical City in Holy capital24211, MeccaWestern Reagan, Saudi Arabia
Sponsors and collaborators
King Abdullah Medical City
Lead sponsor
Source ClinicalTrials.gov